Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1993 1
1995 1
1996 1
1999 1
2000 1
2005 1
2010 1
2011 1
2012 1
2013 2
2014 5
2015 8
2016 4
2017 1
2018 3
2019 4
2020 3
2021 1
2022 4
2023 3
2024 3
2025 2
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Hepatitis B virus infection in children.
Komatsu H, Inui A. Komatsu H, et al. Expert Rev Anti Infect Ther. 2015 Apr;13(4):427-50. doi: 10.1586/14787210.2015.1019867. Epub 2015 Feb 27. Expert Rev Anti Infect Ther. 2015. PMID: 25724218 Review.
Long-term follow-up studies have revealed the clinical outcomes of chronic hepatitis B virus infection in children. A small percentage of chronically infected children develop liver cirrhosis and hepatocellular carcinoma. ...
Long-term follow-up studies have revealed the clinical outcomes of chronic hepatitis B virus infection in children. A small percentag …
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy.
Kojima S, Inoue Y, Karayama M, Hashimoto D, Asada K, Matsuura S, Imokawa S, Matsui T, Matsuda H, Inami N, Kaida Y, Sato J, Ito Y, Fujii M, Toyoshima M, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Kojima S, et al. Clin Lung Cancer. 2026 Apr;27(3):115-126.e5. doi: 10.1016/j.cllc.2025.10.009. Epub 2025 Oct 13. Clin Lung Cancer. 2026. PMID: 41184170
BioAge was calculated using chronological age and seven clinical biomarkers. BioAge acceleration (BioAgeAccel) was defined as the residual derived from the linear regression of BioAge on chronological age. ...BioAgeAccel has additional prognostic value, particularly in the …
BioAge was calculated using chronological age and seven clinical biomarkers. BioAge acceleration (BioAgeAccel) was defined as the res …
Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function.
Kaneko S, Sakura F, Tanita K, Shimbo A, Nambu R, Yoshida M, Umetsu S, Inui A, Okada C, Tsumura M, Yamada M, Suzuki H, Kosaki K, Ohara O, Shimizu M, Morio T, Okada S, Kanegane H. Kaneko S, et al. Immunother Adv. 2023 Nov 24;3(1):ltad027. doi: 10.1093/immadv/ltad027. eCollection 2023. Immunother Adv. 2023. PMID: 38549698 Free PMC article.
Four patients were enrolled and their clinical symptoms before and after the initiation of treatment with JAKi were described. ...
Four patients were enrolled and their clinical symptoms before and after the initiation of treatment with JAKi were described. ...
Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience.
Miyamoto T, Honda Y, Izawa K, Kanazawa N, Kadowaki S, Ohnishi H, Fujimoto M, Kambe N, Kase N, Shiba T, Nakagishi Y, Akizuki S, Murakami K, Bamba M, Nishida Y, Inui A, Fujisawa T, Nishida D, Iwata N, Otsubo Y, Ishimori S, Nishikori M, Tanizawa K, Nakamura T, Ueda T, Ohwada Y, Tsuyusaki Y, Shimizu M, Ebato T, Iwao K, Kubo A, Kawai T, Matsubayashi T, Miyazaki T, Kanayama T, Nishitani-Isa M, Nihira H, Abe J, Tanaka T, Hiejima E, Okada S, Ohara O, Saito MK, Takita J, Nishikomori R, Yasumi T. Miyamoto T, et al. Front Immunol. 2022 Sep 23;13:905960. doi: 10.3389/fimmu.2022.905960. eCollection 2022. Front Immunol. 2022. PMID: 36211342 Free PMC article.
This study aimed to quantify the type I IFN signature in clinically undiagnosed patients and assess clinical characteristics in those with a high IFN signature. ...A JAK inhibitor effectively treated the patient with the PSMB8 mutations. Patients with clinically …
This study aimed to quantify the type I IFN signature in clinically undiagnosed patients and assess clinical characteristics i …
XCR1+ conventional dendritic cell-induced CD4+ T helper 1 cell activation exacerbates cardiac remodeling after ischemic myocardial injury.
Inui H, Nishida M, Ichii M, Nakaoka H, Asaji M, Ide S, Saito S, Saga A, Omatsu T, Tanaka K, Kanno K, Chang J, Zhu Y, Okada T, Okuzaki D, Matsui T, Ohama T, Koseki M, Morii E, Hosen N, Yamashita S, Sakata Y. Inui H, et al. J Mol Cell Cardiol. 2023 Mar;176:68-83. doi: 10.1016/j.yjmcc.2023.01.011. Epub 2023 Feb 3. J Mol Cell Cardiol. 2023. PMID: 36739942 Free article.
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Ikeda M, Matsuda H, Inami N, Kaida Y, Funayama S, Ichikawa S, Goshima S, Suda T. Karayama M, et al. J Immunother Cancer. 2023 Jul;11(7):e007056. doi: 10.1136/jitc-2023-007056. J Immunother Cancer. 2023. PMID: 37500182 Free PMC article. Clinical Trial.
CONCLUSIONS: In this first prospective study for irP, prednisolone at 1 mg/kg/day, tapered over 6 weeks, demonstrated a promising clinical benefit and manageable toxicity, suggesting a potential treatment option for irP. ...
CONCLUSIONS: In this first prospective study for irP, prednisolone at 1 mg/kg/day, tapered over 6 weeks, demonstrated a promising clinica …
Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review.
Tsuchimoto A, Masutani K, Omoto K, Okumi M, Okabe Y, Nishiki T, Ota M, Nakano T, Tsuruya K, Kitazono T, Nakamura M, Ishida H, Tanabe K; Japan Academic Consortium of Kidney Transplantation (JACK) Investigators. Tsuchimoto A, et al. Clin Exp Nephrol. 2019 Apr;23(4):561-568. doi: 10.1007/s10157-018-1672-1. Epub 2018 Dec 24. Clin Exp Nephrol. 2019. PMID: 30584654 Review.
METHODS: In this retrospective multicentre study, we investigated the clinical courses of six ESKD patients that received KT after HSCT for various haematological diseases. ...
METHODS: In this retrospective multicentre study, we investigated the clinical courses of six ESKD patients that received KT after HS …
Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study.
Unagami K, Yoshikawa M, Egawa H, Ohfuji S, Natori Y, Oki R, Mori T, Hattori H, Ishiwatari A, Kanzawa T, Shimizu T, Omoto K, Inui M, Masano Y, Ito T, Nakajima D, Babazono T, Takagi T, Nunoda S, Tomimaru Y, Imamura R, Miyagawa S, Toda K, Hatano E, Date H, Kyakuno M, Takahara S, Yuzawa K, Tanimine N, Ohdan H, Ishida H, Hirota Y; Japan Solid Organ Transplantation COVID-19 Countermeasure Group. Unagami K, et al. Vaccine. 2024 Oct 3;42(23):126221. doi: 10.1016/j.vaccine.2024.126221. Epub 2024 Aug 24. Vaccine. 2024. PMID: 39180977
Macrophage Activation Mechanisms in Human Monocytic Cell Line-derived Macrophages.
Sumiya Y, Ishikawa M, Inoue T, Inui T, Kuchiike D, Kubo K, Uto Y, Nishikata T. Sumiya Y, et al. Anticancer Res. 2015 Aug;35(8):4447-51. Anticancer Res. 2015. PMID: 26168485
BACKGROUND: Although the mechanisms of macrophage activation are important for cancer immunotherapy, they are poorly understood. Recently, easy and robust assay systems for assessing the macrophage-activating factor (MAF) using monocytic cell line-derived macrophages were …
BACKGROUND: Although the mechanisms of macrophage activation are important for cancer immunotherapy, they are poorly understood. Rece …
48 results